Skip to content
  • Tuesday, 27 October 2026
  • 10:36 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • The biotech bi-weekly: an expansion into cardiac drug discovery, the world’s largest healthy human protein atlas and large libraries of AI-designed proteins
Biotech & Genetic Research

The biotech bi-weekly: an expansion into cardiac drug discovery, the world’s largest healthy human protein atlas and large libraries of AI-designed proteins

Jia Lissa Oct 7, 2026 0

The global biotechnology sector continues to experience an unprecedented wave of innovation, marked by significant strides in laboratory reagents, cardiovascular…

Read More
Biotech & Genetic Research

The biotech bi-weekly: an expansion into cardiac drug discovery, the world’s largest healthy human protein atlas and large libraries of AI-designed proteins

Jia Lissa Sep 29, 2026 0

The global biotechnology sector continues to experience rapid advancements across multiple disciplines, ranging from fundamental laboratory tools to advanced artificial…

Read More
Pharmaceutical R&D

Samsung Biologics Accelerates Global Expansion with Strategic US Acquisition and PolyPeptide Deal

Teuku Ryan Jul 22, 2026 0

South Korean contract development and manufacturing organization (CDMO) Samsung Biologics has embarked on a significant phase of global expansion, marked…

Read More
Laboratory Automation & Robotics

Arrowfly Emerges as the New Corporate Identity for WTWH Media, Signaling Strategic Expansion and Market Consolidation

Lana Keisha Jul 20, 2026 0

Cleveland, Ohio – In a significant corporate development signaling a strategic evolution and a unified market approach, WTWH Media, the…

Read More
Pharmaceutical R&D

Sanofi’s Nexviazyme Demonstrates Promising Results in Infants with Infantile-Onset Pompe Disease, Paving Way for Potential Label Expansion

Teuku Ryan Jul 1, 2026 0

Sanofi’s groundbreaking treatment for Pompe disease, Nexviazyme (avalglucosidase alfa), has achieved a significant milestone with the successful completion of the…

Read More
Pharmaceutical R&D

Parabilis Medicines Aims for $475 Million Nasdaq IPO to Fund Pivotal Desmoid Tumour Trial and Pipeline Expansion

Teuku Ryan Jun 5, 2026 0

Parabilis Medicines, a biopharmaceutical company forging innovative therapeutic pathways, is charting a course for public market debut with a proposed…

Read More
Laboratory Automation & Robotics

Immunai’s Digital "Plumbing" Secures Third Expansion with AstraZeneca, Deepening AI Integration Across Clinical Pipeline

Lana Keisha May 29, 2026 0

Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has announced its third significant…

Read More
Pharmaceutical R&D

The Hereditary Angioedema Pharmaceutical Landscape Poised for Unprecedented Expansion Driven by Late-Stage Pipeline and Emerging Technologies

Teuku Ryan May 28, 2026 0

The pharmaceutical landscape for hereditary angioedema (HAE) is on the cusp of a significant transformation, marked by an unprecedented surge…

Read More
Pharmaceutical R&D

Novo Nordisk’s Wegovy Poised for Significant European Expansion Following Positive CHMP Opinions on Oral and High-Dose Injectable Formulations

Teuku Ryan May 27, 2026 0

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has delivered two pivotal positive opinions, paving…

Read More
Neuroscience & Brain Research

Evolutionary Origins of Human Right-Handedness Linked to Bipedalism and Brain Expansion in Landmark Oxford Study

Rifan Muazin May 26, 2026 0

The mystery of why the vast majority of the human population—approximately 90%—favors the right hand has remained one of the…

Read More

Posts pagination

1 2
Science News: A Century of Empowering Public Understanding of Science, Medicine, and TechnologyCopper drug clears toxic Alzheimer’s proteins and restores memoryPharma commercial vendor selection still runs on word of mouth and a Harvard MBA student aims to change that with Rx Almanac.Can the heart heal itself? New study says it can
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ